Liver transplant for liver cancer: eligibility, downstaging and care while waiting
Liver transplantation can treat both selected HCC and the diseased liver in which it developed. Assessment considers tumor number and size, spread beyond the liver, blood vessel involvement, liver function and overall health. Some patients receive treatment to keep cancer controlled while waiting; others may be assessed after successful downstaging. Medical suitability and access to a transplant program are separate questions, so the transplant center needs to explain both before plans are made.
On this page
Why transplant may be considered instead of removing a tumor
Resection removes part of the liver, while transplantation replaces the liver. Transplant can therefore be relevant when cirrhosis or limited reserve makes removal of a liver segment unsuitable, provided the cancer fits accepted selection criteria.
The first discussion should compare transplant assessment with the other realistic treatments. Ask whether the main issue is the cancer's location, the condition of the liver or both. This helps explain why two patients with similarly sized tumors may receive different recommendations.
Sources and references: [1]
How tumor findings influence eligibility
Programs use defined criteria to select patients whose cancer is likely to remain controlled after transplant. Tumor size and number are important, as are major blood vessel invasion and disease outside the liver. AFP and the cancer's behavior during observation or treatment may also contribute.
Ask the transplant service to identify the criteria it uses and explain where your case currently fits. Obtain the original scan images and AFP trend. A short statement that a tumor is small or within criteria does not replace the center's complete assessment.
The assessment extends beyond the liver
A transplant is major surgery followed by ongoing immune-suppressing treatment. Heart and lung function, infection status, other medical problems and the ability to manage follow-up all enter the assessment. Nutritional condition and strength may also need attention during preparation.
Ask which tests or consultations remain outstanding and whether anything can be improved while the assessment proceeds. A written list helps you and your family understand the difference between being referred, completing evaluation and being accepted into a program.
Sources and references: [1]
What downstaging is trying to achieve
Downstaging uses cancer treatment to bring selected tumors into an acceptable range for transplant consideration. Liver-directed treatments may be used, with reassessment of tumor response and behavior afterward. A favorable response can support further evaluation in suitable cases.
Ask what target must be reached and over what observation period. The team should explain how response is measured, what happens if another lesion appears and which treatment is available if transplant remains unsuitable. Downstaging should be planned with the transplant service involved.
Care while waiting for a transplant
Bridging treatment aims to keep the cancer controlled during the waiting period. The choice depends on the tumor and liver reserve. Follow-up includes imaging and laboratory assessment so the service can detect progression or a change in liver function.
Ask who is responsible for the next scan, how results reach the transplant team and which symptoms require urgent care. A missed assessment can leave an important change unrecognized. Keep a calendar shared with the family member helping you manage appointments.
Keep an active plan if transplant is not the next step
Surgery, ablation, arterial treatment, radiation or systemic therapy may be considered depending on the case. A transplant assessment should not leave the cancer without a current management plan. Ask which treatment protects the best options while the evaluation is underway.
If transplant is declined, request an explanation of the specific reason and the alternatives. Some barriers relate to cancer extent; others relate to overall health or program requirements. Knowing the reason helps determine whether further treatment or another specialist review would change the decision.
Clarify the program pathway before travel
A medical opinion about HCC is different from acceptance for transplant listing. The responsible program must explain its eligibility, donation and allocation processes, as well as the care arrangements required after surgery. These questions are particularly important for people seeking care outside their home country.
Ask the program directly which pathway applies to your circumstances and what documentation is needed. Avoid committing to a travel timetable around an assumed transplant date. For an initial opinion, the immediate task may simply be a review of the cancer and current liver treatment options.
Sources and references: [1]
A Shanghai consultation for the HCC decision
Zhongshan Hospital is a liver cancer resource for discussing the overall treatment pathway. Bring recent imaging, AFP and liver tests, previous treatment records and any transplant center correspondence so the review addresses the decision already under consideration.
EastMedGo can help organize a liver cancer consultation and clarify administrative requirements with the receiving service. Transplant listing and donation decisions stay with authorized clinical programs. We can support the consultation arrangements and explain coordination costs while you establish a medically and practically appropriate next step.
Sources and references: [4]
Common questions
Does successful downstaging mean I am listed automatically?
No. The transplant program reassesses the cancer and completes the broader medical and program evaluation. Ask which remaining steps apply to you.
Can liver cancer return after transplant?
Recurrence remains possible, which is why careful selection and follow-up matter. The transplant team should explain the risk factors relevant to your case.
Sources and references: [1]
What is the difference between bridging and downstaging?
Bridging aims to maintain control while waiting. Downstaging aims to reduce selected disease to a range that may support transplant consideration.
Sources and references: [2]
Sources and references
- Primary Liver Cancer Treatment (PDQ) – Health Professional Version
- Hepatology Practice Questions, Edition 1
- Liver Cancer Treatment
- Zhongshan Hospital Affiliated to Fudan University
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.